Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
Jharna Datta(The Ohio State University), Mathew Cherian(The Ohio State University Wexner Medical Center)
Cited by 20
Related Papers
Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398
|Molecular Cancer Therapeutics|2017|93
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness
|npj Breast Cancer|2021|37
An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia
|Journal of Biological Chemistry|2018|27
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
|Breast Cancer Research|2024|7
Augmentation of extracellular ATP synergizes with chemotherapy in triple negative breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0